Belgium: Dechamps appointed as CEO of Bioxodes to spearhead funding efforts

Bioxodes, a company specializing in the development of therapies for the prevention and treatment of thrombotic and inflammatory diseases, has appointed Marc Dechamps as its new CEO. Company founder, Edmond Godfroid, will take up the post of Chief Operations Officer alongside his existing responsibilities as Chief Scientific Officer (CSO). As CEO, Dechamps will take on…